Molecular Marker Testing in Curable Non-Small Cell Lung Cancer-Practice Necessarily Precedes Data.

JAMA oncology（2023）

Cited 1|Views14

No score

Abstract

This Viewpoint describes the use of broad molecular marker testing in patients with early-stage non-small cell lung cancer

Translated text

Key words

molecular marker testing,non–small cell lung cancer—practice,lung cancer—practice

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined